newsfilter
← Latest News
PR Newswire·

Halozyme to Participate in Upcoming Investor Conferences

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, President and Chief Executive Officer, is scheduled to ...